Good evening and welcome to Markets Desk, your end-of-day read on what's moving markets and why.
The energy complex remains on edge as the conflict with Iran stretches toward a longer timeline than many traders had priced in. Intelligence and industry sources suggest the Strait of Hormuz, while contested, has not been fully closed, with meaningful volumes of crude still moving through the waterway. That partial flow is tempering the oil spike, but analysts warn a major escalation remains probable, potentially extending hostilities deep into two thousand twenty seven. How much supply actually leaks through that chokepoint will be the defining variable for energy markets in the months ahead.
Shifting to tech, the Oracle versus Amazon debate is sharpening as investors size up the artificial intelligence cloud buildout over a five-year horizon. Oracle's infrastructure is drawing attention for its cost efficiency and architecture suited to large AI workloads, though its heavy reliance on OpenAI as a flagship client introduces meaningful concentration risk that has kept some institutional money on the sidelines.
On the dividend front, Abbott Laboratories and Johnson and Johnson are both drawing fresh scrutiny from income-focused investors. Abbott has navigated a difficult stretch operationally, but the fundamental case for its dividend growth trajectory remains intact, putting it squarely in competition with the more established Johnson and Johnson for long-term yield portfolios.
That's the tape. Markets Desk, signing off the floor.
